VV

Vivek Valsaraj

Active Director Whole-Time Director DIN 06970246
DIN 06970246 First appointment Sep 2014 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 6 historical roles
Total affiliations 8 Since Sep 2014
Shareholding value •••• Premium profile

About Vivek Valsaraj

Data last updated:

Vivek Valsaraj is a Whole-Time Director at Piramal Pharma Limited (since 2022) and Director at Abbvie Therapeutics India Private Limited (since 2022). The companies operate in Pharma, Healthcare and Financial Services. The 2 current companies with reported revenue have a combined latest revenue of ₹9,615 Cr; the largest is Piramal Pharma Limited at ₹9,082 Cr (FY 2026). Earlier, Vivek Valsaraj was a Director at Drg Analytics & Insights Private Limited (2019–2020) and Cfo at Piramal Enterprises Limited (2017–2022) and 4 more.

DIN 06970246
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 18 Sep 2014
Oldest Company Age 32 yrs
Largest company Piramal Pharma Limited · ₹9,082 Cr (FY 2026)
Combined revenue ₹9,615 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Piramal Pharma Limited L24297MH2020PLC338592
Whole-Time Director09 Feb 20222020₹9,082 Cr (FY 2026)Active
Director22 Feb 20221994₹533 Cr (FY 2026)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Mar 20192015₹128 Cr (FY 2025)Active
Piramal Enterprises Limited L24110MH1947PLC005719
Cfo01 Dec 20171947₹10,612 Cr (FY 2025)Amalgamated
Searchlight Health Private Limited U85100KA2007PTC124079
Nominee Director16 Aug 20192007₹1.99 Cr (FY 2025)Active
Additional Director22 Jun 20211979₹133 Cr (FY 2021)Amalgamated
Director19 Nov 20142014₹120 Cr (FY 2021)Amalgamated
Additional Director18 Sep 20142008Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Convergence Chemicals Private Limited
Piramal Pharmaceutical Development Services Private Limited
Piramal Pharma Limited
Abbvie Therapeutics India Private Limited
Premium access

Shareholding and investment profile for Vivek Valsaraj

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vivek Valsaraj

Vivek Valsaraj currently holds 2 directorships: Piramal Pharma Limited (Whole-Time Director, since 09 Feb 2022, revenue ₹9,082 Cr (FY 2026)); Abbvie Therapeutics India Private Limited (Director, since 22 Feb 2022, revenue ₹533 Cr (FY 2026)).

Vivek Valsaraj was first appointed on 18 Sep 2014 as Additional Director at Piramal Pharmaceutical Development Services Private Limited. The most recent appointment on record is 22 Feb 2022 at Abbvie Therapeutics India Private Limited.

The 2 current companies of Vivek Valsaraj that report revenue have a combined latest revenue of ₹9,615 Cr: Piramal Pharma Limited ₹9,082 Cr (FY 2026); Abbvie Therapeutics India Private Limited ₹533 Cr (FY 2026).

Vivek Valsaraj held 6 earlier board appointments: Drg Analytics & Insights Private Limited (Director, 13 Mar 2019 to 28 Feb 2020); Piramal Enterprises Limited (Cfo, 01 Dec 2017 to 18 Aug 2022); Searchlight Health Private Limited (Nominee Director, 16 Aug 2019 to 15 Apr 2020); Hemmo Pharmaceuticals Private Limited (Additional Director, 22 Jun 2021 to 26 Nov 2021); Convergence Chemicals Private Limited (Director, from 19 Nov 2014); and 1 more.

The current boards of Vivek Valsaraj's companies include Amit Jain (Piramal Pharma Limited), Amit Soni (Piramal Pharma Limited), Jairaj Manohar Purandare (Piramal Pharma Limited), Maneesh Sharma (Piramal Pharma Limited), Nandini Ajay Piramal (Piramal Pharma Limited), Nathalie Ann Leitch (Piramal Pharma Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available